Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
Further Reading from MarketBeat.com The 3 Penny Stocks You Swore You'd Never Buy (But You'll Check Anyway)Reported by Chris Markoch. Originally Published: 1/18/2026. 
Key Points - Vaxart is a clinical-stage biotech developing oral vaccines that could transform global immunization if its platform proves effective.
- Microvision develops cost-effective lidar technology for autonomous vehicles, with upside tied to industry adoption and potential partnerships.
- Datavault AI focuses on monetizing digital data through AI and blockchain tools, offering speculative exposure to the emerging data-as-an-asset theme.
Penny stocks attract speculative investors searching for high-risk, high-reward opportunities. These names often represent companies with disruptive technologies, exposure to an emerging trend, or a compelling turnaround story. Many will never scale or survive, but if one does, returns can be impressive. For investors who believe strength lies in numbers, MarketBeat offers a tool that lists the 100 Most Popular Penny Stocks, ranked by the number of MarketBeat subscribers following each company. That isn't a guarantee of success, but it can help investors gauge interest and build conviction. Gold has weathered every financial disaster in history, and it's up more than 100 percent in the last two years. But there's another reason to pay attention now. Since 1950, roughly 70 percent of all the gold on earth has already been mined. What remains is harder to find and more costly to extract. Supplies are running out at the exact moment the world needs gold to stabilize heavily indebted financial systems. A four-stock portfolio of top gold developers is now available, selling at an average 82 percent discount to asset value. Get the four picks plus a bonus stock with potential for significant upside. Some investors call any stock trading at $5 or less a penny stock. This screener uses the traditional definition: stocks trading under $1. These shares are highly volatile; do your own research and understand your risk tolerance before taking a position. Vaxart: A Potential Game-Changer for Global Immunization Efforts Vaxart Inc. (NASDAQ: VXRT) is a clinical-stage biotechnology company developing oral vaccines for infectious diseases, including influenza, norovirus, and COVID-19. Instead of injections, Vaxart's tablet-based platform aims to simplify distribution and improve global accessibility. The bull case centers on that innovative delivery approach. If Vaxart can obtain FDA approval and scale production, its oral vaccines could reduce logistical barriers for mass immunization and create licensing opportunities. Positive trial data or a commercial collaboration could materially change sentiment and valuation given the stock's current low base. Clinical risk remains the biggest challenge. Vaxart has not yet brought a product to market, and vaccine development is costly and unpredictable. Competition from established players with larger R&D budgets also limits visibility. For now, Vaxart is a long-term speculative bet on platform validation rather than near-term profitability. The MarketBeat analyst ratings show only a single analyst covering the stock, which may raise concerns for some investors. Additionally, VXRT has just 18% institutional ownership. On a more positive note, relatively low short interest (about 2%) may temper some volatility. Microvision: Developing Cost-Effective LiDAR Units For Autonomous Driving Microvision Inc. (NASDAQ: MVIS) develops LiDAR (light detection and ranging) sensors for autonomous vehicles, smart infrastructure, and industrial sensing. Its hardware and software enable precise 3D mapping needed for self-driving systems and advanced driver-assistance systems (ADAS). Microvision focuses on compact, cost-effective LiDAR units that could appeal to automakers seeking scalable sensor solutions. The bull case depends on continued progress toward vehicle automation and potential partnerships with major automakers. If Microvision can demonstrate performance or cost advantages, it could win supply agreements or licensing deals that improve revenue visibility. The technology also has potential beyond vehicles—in robotics and smart cities—adding optionality to the growth story. Despite the promise, Microvision faces stiff competition from LiDAR players such as Luminar (NASDAQ: LAZR), Innoviz (NASDAQ: INVZ), and Ouster (NYSE: OUST). The path to profitability is uncertain, and delays in commercial LiDAR adoption have frustrated investors. MVIS is covered by three analysts and has a consensus price target of $2.50, about a 169% rise from its Jan. 15 closing price. Like many speculative names, Microvision has relatively low institutional ownership (around 30%) and high short interest (around 21%), so investors should expect significant volatility. Datavault AI: Trying to Democratize Data Ownership Datavault AI Inc. (NASDAQ: DVLT) operates at the intersection of artificial intelligence, data monetization, and digital asset management. The company helps organizations turn raw data into tradable, revenue-generating assets through its Datavault platform. By combining AI, blockchain, and analytics, Datavault AI aims to democratize data ownership and enable new monetization opportunities. The bullish thesis rests on a niche focus and scalability potential. As data becomes more valuable, businesses—and potentially individuals—are seeking ways to monetize digital information while retaining control. Datavault's technology could benefit from broader AI adoption and growing awareness of data sovereignty; early traction or strategic partnerships could boost investor confidence. That said, Datavault AI operates in a highly experimental space. The business model is still evolving, and the path to meaningful revenue is unproven. Institutional ownership is under 1%, and short interest exceeds 16% as of this writing. Investors should view DVLT as a long-term, speculative position based on belief in data-as-an-asset innovation rather than near-term earnings potential.
| 
